Page last updated: 2024-08-24

norharman and Angiogenesis, Pathologic

norharman has been researched along with Angiogenesis, Pathologic in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cao, R; Chen, W; Dai, B; Fan, W; Guo, L; Ma, Q; Zhang, J1

Other Studies

1 other study(ies) available for norharman and Angiogenesis, Pathologic

ArticleYear
Synthesis and structure-activity relationships of asymmetric dimeric β-carboline derivatives as potential antitumor agents.
    European journal of medicinal chemistry, 2018, Mar-10, Volume: 147

    Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Carbolines; Cell Line, Tumor; Cell Movement; Cell Proliferation; Dimerization; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Mice; Mice, Inbred Strains; Molecular Structure; Neovascularization, Pathologic; Structure-Activity Relationship; Wound Healing

2018